Don’t Ignore That Cough: RSV Is on the Rise in Adults

As the colder months approach, many adults brace for the usual suspects: colds, flu, and now COVID-19. However, another virus is silently spreading, often mistaken for a common cold but potentially far more dangerous—Respiratory Syncytial Virus (RSV). Traditionally seen as a childhood illness, RSV is increasingly affecting adults, particularly those with weakened immune systems, chronic conditions, and those over 60.

Understanding RSV in Adults

RSV is a contagious virus that infects the respiratory tract. While RSV is most commonly associated with infants and young children, it’s also a growing concern for adults, especially those with certain medical conditions or those living in nursing homes. The Centers for Disease Control and Prevention (CDC) reports that each year, RSV leads to an estimated 60,000-160,000 hospitalizations and 6,000-10,000 deaths among older adults in the United States.¹
Symptoms of RSV in adults, including cough, sneezing, runny nose, and fever, can easily be mistaken for the flu or a common cold. However, in more severe cases, RSV can lead to lung infections or pneumonia, and it can worsen existing conditions like asthma, chronic obstructive pulmonary disease (COPD), and congestive heart failure.

Prevention and Protection

Preventing RSV is crucial, especially for those at higher risk. Basic hygiene practices that were drilled into us early in the COVID-19 pandemic, such as frequent handwashing, avoiding close contact with sick individuals, and disinfecting surfaces, can reduce the risk of infection of RSV as well. 

Prevention can only protect you so far, however. So if you fall within the high-risk categories, it’s important to consult your healthcare provider about the RSV vaccine. The best time to get vaccinated is in late summer or early fall to ensure protection when RSV starts to spread.